Literature DB >> 12671311

Assay of antioxidant capacity of human plasma and CSF in aging and disease.

H Alho1, J S Leinonen, M Erhola, K Lönnrot, R Aejmelaeus.   

Abstract

Oxidative damage to DNA and other macromolecules accumulates with age and has been postulated to be one of the major forms of endogenous damage leading to aging and has been implicated also in initiation of cancer and over a hundred other diseases. The human body has developed an antioxidant (AOX) defense system which contains enzymatic, metal chelating, and free radical scavenging properties. Thus, it is essential to consider the concentration of all AOXs in plasma and CSF when investigating the relationship between diet, oxidative stress, and disease. In the present study a luminometric TRAP-method (total peroxyl radical-trapping potential) was used to determine the activity of all chain breaking AOXs in several clinical states. We have measured TRAP of plasma, cerebrospinal fluid (CSF) and of low density lipoprotein (LDL, TRAPLDL), and the concentrations of main AOX-components (uric acid, protein SH-groups, alpha-tocopherol, ascorbic acid, ubiquinone and the fraction of unknown antioxidants) to study the effect of: 1) aging, 2) acute infection, 3) diabetes, 4) immobilization and 5) cancer. TRAP of CSF is five times lower than of plasma, mainly due to the low urate concentration in CSF. We have observed that plasma antioxidant defenses respond to the basic metabolic rate and the challenges caused by physiological or pathological stress: i) in a healthy normal population TRAP and TRAPLDL change with age and a substantial proportion of TRAP cannot be attributed to any known AOXs thus indicating the existence of unmeasured an unidentified antioxidant(s); ii) during acute infection and immobilization the exogenous AOXs (vitamin C and E) remained unchanged, whereas the activity of unidentified AOXs of plasma declined sharply; iii) in those NIDDM patients with coronary heart disease plasma TRAP is reduced. In conclusion, TRAP has revealed important information for evaluating the AOX status of human plasma, CSF and LDL. According to our studies, important, possibly endogenous AOXs still remain to be identified.

Entities:  

Year:  1998        PMID: 12671311

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  10 in total

1.  Serotonin as a putative scavenger of hypohalous acid in the brain.

Authors:  Mike Kalogiannis; E James Delikatny; Thomas M Jeitner
Journal:  Biochim Biophys Acta       Date:  2015-12-14

2.  Effect of acute administration of 3-butyl-1-phenyl-2-(phenyltelluro)oct-en-1-one on oxidative stress in cerebral cortex, hippocampus, and cerebellum of rats.

Authors:  Cláudia Funchal; Carlos Augusto Souza Carvalho; Tanise Gemelli; Andressa S Centeno; Robson Brum Guerra; Mirian Salvador; Caroline Dani; Adriana Coitinho; Rosane Gomez
Journal:  Cell Mol Neurobiol       Date:  2010-07-29       Impact factor: 5.046

3.  SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

Authors:  Andrea M Vincent; James W Russell; Kelli A Sullivan; Carey Backus; John M Hayes; Lisa L McLean; Eva L Feldman
Journal:  Exp Neurol       Date:  2007-08-03       Impact factor: 5.330

4.  Urate as a predictor of the rate of clinical decline in Parkinson disease.

Authors:  Alberto Ascherio; Peter A LeWitt; Kui Xu; Shirley Eberly; Arthur Watts; Wayne R Matson; Connie Marras; Karl Kieburtz; Alice Rudolph; Mikhail B Bogdanov; Steven R Schwid; Marsha Tennis; Caroline M Tanner; M Flint Beal; Anthony E Lang; David Oakes; Stanley Fahn; Ira Shoulson; Michael A Schwarzschild
Journal:  Arch Neurol       Date:  2009-12

5.  Effect of in vitro exposure of human serum to 3-butyl-1-phenyl-2-(phenyltelluro)oct-en-1-one on oxidative stress.

Authors:  Carlos Augusto Souza Carvalho; Tanise Gemelli; Robson Brum Guerra; Lívia Oliboni; Mirian Salvador; Caroline Dani; Alex Sander Araújo; Marcello Mascarenhas; Cláudia Funchal
Journal:  Mol Cell Biochem       Date:  2009-06-25       Impact factor: 3.396

6.  Cardiovascular risk factors and total serum antioxidant capacity in healthy men and in men with coronary heart disease.

Authors:  Anna Gawron-Skarbek; Jacek Chrzczanowicz; Joanna Kostka; Dariusz Nowak; Wojciech Drygas; Anna Jegier; Tomasz Kostka
Journal:  Biomed Res Int       Date:  2014-08-11       Impact factor: 3.411

7.  Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated LRRK2 Gene Mutations.

Authors:  David A Loeffler; Andrea C Klaver; Mary P Coffey; Jan O Aasly; Peter A LeWitt
Journal:  Front Aging Neurosci       Date:  2017-04-03       Impact factor: 5.750

Review 8.  What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?

Authors:  David A Loeffler; Jan O Aasly; Peter A LeWitt; Mary P Coffey
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

9.  Influence of Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Oxidative Stress Intensity in Minimally Conscious State Patients.

Authors:  Katarzyna Jezierska-Wozniak; Emilia Sinderewicz; Wioleta Czelejewska; Pawel Wojtacha; Monika Barczewska; Wojciech Maksymowicz
Journal:  J Clin Med       Date:  2020-03-03       Impact factor: 4.241

10.  Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal Aging.

Authors:  David A Loeffler; Andrea C Klaver; Mary P Coffey; Jan O Aasly
Journal:  Front Aging Neurosci       Date:  2018-05-08       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.